Sivik Global Healthcare LLC Sells 25,000 Shares of SPDR S&P Biotech ETF $XBI

Sivik Global Healthcare LLC reduced its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 10.0% during the fourth quarter, Holdings Channel.com reports. The fund owned 225,000 shares of the exchange traded fund’s stock after selling 25,000 shares during the quarter. SPDR S&P Biotech ETF accounts for approximately 8.0% of Sivik Global Healthcare LLC’s investment portfolio, making the stock its largest position. Sivik Global Healthcare LLC’s holdings in SPDR S&P Biotech ETF were worth $27,434,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. JPMorgan Chase & Co. raised its holdings in SPDR S&P Biotech ETF by 27.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 13,538,738 shares of the exchange traded fund’s stock worth $1,356,582,000 after buying an additional 2,900,633 shares during the period. Bessemer Group Inc. raised its holdings in SPDR S&P Biotech ETF by 9.3% during the 3rd quarter. Bessemer Group Inc. now owns 1,632,988 shares of the exchange traded fund’s stock worth $163,624,000 after buying an additional 138,322 shares during the period. Ameriprise Financial Inc. raised its holdings in SPDR S&P Biotech ETF by 40.5% during the 3rd quarter. Ameriprise Financial Inc. now owns 1,226,147 shares of the exchange traded fund’s stock worth $122,906,000 after buying an additional 353,351 shares during the period. Meitav Investment House Ltd. raised its holdings in SPDR S&P Biotech ETF by 70.3% during the 3rd quarter. Meitav Investment House Ltd. now owns 682,056 shares of the exchange traded fund’s stock worth $68,156,000 after buying an additional 281,602 shares during the period. Finally, Greenhouse Funds LLLP raised its holdings in SPDR S&P Biotech ETF by 16.6% during the 3rd quarter. Greenhouse Funds LLLP now owns 675,975 shares of the exchange traded fund’s stock worth $67,733,000 after buying an additional 96,308 shares during the period.

SPDR S&P Biotech ETF Trading Up 0.0%

NYSEARCA XBI opened at $128.85 on Wednesday. The stock’s 50-day moving average price is $125.02 and its two-hundred day moving average price is $119.02. The company has a market cap of $7.85 billion, a PE ratio of 11.47 and a beta of 0.91. SPDR S&P Biotech ETF has a 1 year low of $66.66 and a 1 year high of $132.09.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.